Cyclacel Pharmaceuticals Inc. Stock
The sentiment is rather negative at the moment with 13 Sell predictions and 1 Buy predictions.
However, we have a potential of 8536.36% for Cyclacel Pharmaceuticals Inc. as the target price of 19 € is above the current price of 0.22 €.
For the coming years our community has positive and negative things to say abot the Cyclacel Pharmaceuticals Inc. stock. Criterium "EBIT Margin" gathered the most positive votes but regarding "Expected Cash Flow" there were negative voices in the community.
Pros and Cons of Cyclacel Pharmaceuticals Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cyclacel Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cyclacel Pharmaceuticals Inc. | - | - | - | - | - | - | - |
| Vaxart Inc. | 1.730% | -7.644% | -44.648% | -9.739% | 28.879% | -91.245% | - |
| Jaguar Health Inc. | 0.640% | 11.059% | 131.656% | 141.432% | 25.033% | -99.933% | - |
| aTyr Pharma Inc | -1.380% | -1.361% | -20.765% | -17.614% | 12.403% | -57.602% | -82.651% |
Comments
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for CYCC provided by MarketBeat
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for CYCC provided by MarketBeat
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for CYCC provided by MarketBeat